Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Long-term effects of Xuezhikang on blood pressure in hypertensive patients with previous myocardial infarction: data from the Chinese Coronary Secondary Prevention Study (CCSPS).

Li JJ, Lu ZL, Kou WR, Chen Z, Wu YF, Yu XH, Zhao YC; Chinese Coronary Secondary Prevention Study (CCSPS) Group..

Clin Exp Hypertens. 2010;32(8):491-8. doi: 10.3109/10641961003686427.

PMID:
21091365
2.

Impact of Xuezhikang on coronary events in hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS).

Li JJ, Lu ZL, Kou WR, Chen Z, Wu YF, Yu XH, Zhao YC; Chinese Coronary Secondary Prevention Study Group..

Ann Med. 2010 Apr;42(3):231-40. doi: 10.3109/07853891003652534.

PMID:
20350253
3.

Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS).

Li JJ, Lu ZL, Kou WR, Chen Z, Wu YF, Yu XH, Zhao YC; Chinese Coronary Secondary Prevention Study Group..

J Clin Pharmacol. 2009 Aug;49(8):947-56. doi: 10.1177/0091270009337509.

PMID:
19602720
4.

Clinical efficiency and safety analysis of transcatheter closure of multiple atrial septal defects in adults.

Song ZY, He GX, Shu MQ, Hu HY, Tong SF, Ran BL, Liu JP, Li YH, Jing T.

Clin Cardiol. 2009 Mar;32(3):130-4. doi: 10.1002/clc.20450.

5.

Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction.

Lu Z, Kou W, Du B, Wu Y, Zhao S, Brusco OA, Morgan JM, Capuzzi DM; Chinese Coronary Secondary Prevention Study Group., Li S.

Am J Cardiol. 2008 Jun 15;101(12):1689-93. doi: 10.1016/j.amjcard.2008.02.056. Epub 2008 Apr 11.

PMID:
18549841
6.

RNA interference targeting ORC1 gene suppresses the proliferation of vascular smooth muscle cells in rats.

Shu MQ, Qin YL, Jiang MH.

Exp Mol Pathol. 2008 Jun;84(3):206-12. doi: 10.1016/j.yexmp.2008.03.001. Epub 2008 Mar 21.

PMID:
18499104
7.

Clinical efficiency and safety analysis of transcatheter interventional therapy for compound congenital cardiovascular abnormalities.

Song ZY, Shu MQ, Hu HY, Tong SF, Ran BL, Liu JP, Li YH, He GX.

Clin Cardiol. 2007 Oct;30(10):518-21.

8.

[Expression of origin recognition complex 1 gene in DNA replication of vascularsmooth muscle cells].

Jiang MH, Shu MQ, Qin YL, Wang Q.

Zhonghua Bing Li Xue Za Zhi. 2007 Feb;36(2):122-5. Chinese.

PMID:
17493388
9.

Relationship between intravascular ultrasound imaging features of coronary plaques and soluble CD105 level in patients with coronary heart disease.

Cui S, Lü SZ, Chen YD, He GX, Liu JP, Song ZY, Shu MQ, Hu HY, Ran BL, Jing T.

Chin Med J (Engl). 2007 Apr 5;120(7):595-7. No abstract available.

PMID:
17442209
10.

[Transcatheter closure of perimembrane ventricular septal defect using Amplatzer occluder device].

Song ZY, He GX, Shu MQ, Hu HY, Zhang P, Tong SF, Cheng XM, Ran BL, Zhuang GQ.

Zhonghua Er Ke Za Zhi. 2004 Nov;42(11):862-3. Chinese. No abstract available.

PMID:
15631720

Supplemental Content

Loading ...
Support Center